Skip to main content
Premium Trial:

Request an Annual Quote

Applied Markets Watch: IntegenX Launches Human ID System in Europe


IntegenX this week launched its RapidHit 200 Human DNA Identification System in Europe.

The RapidHit 200 is a fully automated and closed sample-to-profile DNA analysis system that integrates cell lysis, DNA extraction, PCR amplification, capillary electrophoresis-based separation, and laser-induced fluorescence detection.

The system can produce DNA profiles from buccal swabs or other human samples in less than 90 minutes, and will enable DNA analysis at the point of collection, such as an arrest or detention, according to the company.

IntegenX, based in Pleasanton, Calif., plans to market the system for use in field-based applications in forensics, defense, homeland security, and other markets.

The company launched its system this week at the European Academy of Forensic Science conference in The Hague, The Netherlands. It said that it plans to launch the platform in the US market at the International Association of Chiefs of Police Conference and Law Enforcement Education and Technology Symposium, to be held Sept. 20-Oct. 3 in San Diego.

Earlier this year IntegenX acquired SV Corp from GE Healthcare Biosciences for its IP covering CE, separation, and sample prep (PCR Insider, 5/2/2012). The company also has a reagent supply agreement with Promega for that company's nucleic acid purification and short tandem repeat amplification reagents (PCR Insider, 8/4/2011).

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.